LINGO1, along with LINGO2 and LINGO3, promotes lysosomal degradation of APP in immortalized cell lines of AD, leading to a decrease in Aβ production from the amyloidogenic pathway [13], while beneficial effects of LINGO1 blockage on amyloid burden have also been reported in AD mouse models [23]. The gene discussed is APP; the disease is Alzheimer disease.